EUVIMEDEUVIMED entdecken
FallberichtSystematische ÜbersichtOpen Access · CC BY-NC 3.0

Hypersensitivity in ALK-positive lung cancers exposed to ALK inhibitors: a case of successful switch to an alternative ALK inhibitor and systematic review of the literature

Lei Deng, Janaki Sharma, Elizabeth Ravera, Balazs Halmos, Haiying Cheng

Lung Cancer: Targets and Therapy · 2018-09 · Volume 9 · 73-77

DOI: 10.2147/lctt.s173948 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Lung Cancer: Targets and Therapy, 2018-09. Verfasst von Lei Deng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

alectinibbrigatinib

Autor:innen und Institutionen

  • Department of Medicine, Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA.
  • Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA, hcheng@montefiore.org.

Zitieren

APA

Deng, L., Sharma, J., Ravera, E., Halmos, B., & Cheng, H. (2018). Hypersensitivity in ALK-positive lung cancers exposed to ALK inhibitors: a case of successful switch to an alternative ALK inhibitor and systematic review of the literature. Lung Cancer: Targets and Therapy, Volume 9, 73-77. https://doi.org/10.2147/lctt.s173948

Vancouver

Deng L, Sharma J, Ravera E, Halmos B, Cheng H. Hypersensitivity in ALK-positive lung cancers exposed to ALK inhibitors: a case of successful switch to an alternative ALK inhibitor and systematic review of the literature. Lung Cancer: Targets and Therapy. 2018;Volume 9:73-77. doi:10.2147/lctt.s173948

BibTeX
@article{Deng2018,
  author = {Deng, Lei and Sharma, Janaki and Ravera, Elizabeth and Halmos, Balazs and Cheng, Haiying},
  title = {Hypersensitivity in ALK-positive lung cancers exposed to ALK inhibitors: a case of successful switch to an alternative ALK inhibitor and systematic review of the literature},
  journal = {Lung Cancer: Targets and Therapy},
  year = {2018},
  volume = {Volume 9},
  pages = {73--77},
  doi = {10.2147/lctt.s173948}
}
Kostenlos starten →